Platelet-rich Plasma in the Sacroiliac Joint
Completed · Not applicable
Conditions studied: Sacroiliac Joint Arthritis
In brief
This is a double-blinded study where the injecting physicians and the patients will not know which arm they are randomized to. Each participant will be followed up for 6 months following the injection, and will have in office visits at the injection and approximately 2 weeks post injection. They will be called at month 1, 3, and 6 post injection to assess for any adverse events and number of physical therapy hours or changes in medication. At time of injection, 2 weeks post, and 1, 3 and 6 months after they will be asked to answer some questionnaires on pain and function.
Key facts
- Study ID
- NCT03744234
- Run by
- Columbia University
- People needed
- 40
- Starts
- 2016-12-01
- Expected to finish
- 2019-09-16
- Last updated by the study team
- 2019-09-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Aged 18 years and older
- Sacroiliac/Lower back pain
- Positive block
- Eligible for steroid injection
- Positive physical manual assessments
You may not qualify if…
- Steroid allergy
Where it is running
- Columbia University Irving Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.